Enhanced antitumor efficacy of bispecific antibody blocking PD-L1 and LAG-3 with doxorubicin: mechanism and safety evaluation. - Zhang C; Liu J; Gu T; Meng X; Cai X; Zhang J; Chen Y; Zhang D; Wu Y (Breast cancer research and treatment, 2025)